Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Thyrocare Technologies Limited

Capitalization 86.2B 901M 781M 718M 675M 1.26B 1.28B 8.49B 3.31B 41.52B 3.38B 3.31B 144B P/E ratio 2026
34.2x
P/E ratio 2027 * 44.1x
Enterprise value 86.2B 901M 781M 718M 675M 1.26B 1.28B 8.49B 3.31B 41.52B 3.38B 3.31B 144B EV / Sales 2026
6.71x
EV / Sales 2027 * 8.78x
Free-Float
38.91%
Yield 2026
2.67%
Yield 2027 * 1.99%
1 day+4.51%
1 week+3.64%
Current month+6.92%
1 month+11.27%
3 months+46.37%
6 months+28.22%
Current year+21.46%
1 week 495
Extreme 495
549
1 month 445
Extreme 445
549
Current year 342.55
Extreme 342.55
549
1 year 318.07
Extreme 318.0667
549
3 years 153.67
Extreme 153.6667
549
5 years 138.47
Extreme 138.4667
549
10 years 135.72
Extreme 135.7167
549
Manager TitleAgeSince
Chief Executive Officer - 2022-05-03
Director of Finance/CFO - 2025-07-23
Chief Operating Officer - 2025-12-17
Director TitleAgeSince
Director/Board Member - 2017-08-11
Chairman - -
Director/Board Member - 2023-07-13
Change 5d. change 1-year change 3-years change Capi.($)
+4.51%+3.64% - - 862M
-0.85%-2.44%+30.36%+337.26% 30.84B
-1.18%+2.00%+3.17%+18.70% 21.74B
+1.47%+4.86%-26.35%-43.85% 6.76B
-0.33%+2.40%-7.66%+71.07% 4.27B
+0.59%-1.99%+8.63%+54.01% 2.7B
-2.54%-10.20%-21.97%-66.81% 1.64B
-0.61%-4.57%+11.78%-3.70% 1.56B
-0.79%-0.38%-28.13%+673.13% 1.55B
-3.39%-10.67%+8.77%-33.62% 1.52B
Average -0.31%-2.69%-2.38%+111.80% 8.06B
Weighted average by Cap. -0.67%-1.00%+10.60%+163.09%

Financials

2026 2027 *
Net sales 8.23B 86M 74.52M 68.56M 64.43M 120M 122M 810M 316M 3.96B 323M 316M 13.78B 9.82B 103M 88.9M 81.79M 76.86M 143M 145M 966M 377M 4.73B 385M 377M 16.44B
Net income 1.57B 16.42M 14.23M 13.09M 12.3M 22.91M 23.27M 155M 60.32M 757M 61.65M 60.31M 2.63B 1.98B 20.74M 17.97M 16.53M 15.54M 28.93M 29.38M 195M 76.17M 956M 77.85M 76.16M 3.32B
Net Debt - -
Logo Thyrocare Technologies Limited
Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It offers a range of diagnostic and related healthcare tests and services that are focused on early detection, preventive care, and ongoing disease monitoring. Its segments include diagnostic testing services, Imaging Services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services include diagnostic and imaging services, the selling of radiopharmaceuticals, and consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and the selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, and a medical cyclotron facility across India. It is also focused on offering pathological services.
Employees
1,822
Calendar
Date Price Change Volume
26-06-08 541.35 +4.51% 1,411,955
26-06-05 518.00 -0.53% 89,511
26-06-04 520.75 -0.85% 283,959
26-06-03 525.20 +0.68% 312,888
26-06-02 521.65 -0.13% 503,536
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
541.55INR
Average target price
600.00INR
Spread / Average Target
+10.79%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW